is compound tirzepatide going away Should I switch to Mounjaro now that compounded gone? Tirzepatide compounded: Can you still

Until recently they have had little support from the two dominant GLP-1 drug makers, Novo Nordisk and Eli Lilly who have not considered addition a high prioroty (Sheridan)

The two obesity market leaders, with their blockbuster injectables, have left room for an oral, or pill, market to be a new meaningful target for newer players, according to investors

10.1093/nar/gkad944 96 HarrisM

30-53% of new cases are directly linked to obesity

Exenatide exhibited similar glucose lowering efficacy to long-acting insulin glargine in patients with type 2 diabetes with suboptimal glycemic control despite metformin and sulfonylurea treatment [44]

These campaigns should target children, schools, and families to instill long-term healthy habits